Polyarthritis: Difference between revisions
No edit summary |
No edit summary |
||
Line 46: | Line 46: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Other | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Other | ||
|- | |- | ||
! rowspan=" | ! rowspan="22" style="background: #DCDCDC; padding: 5px; text-align: center;" |Polyarthritis | ||
! rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Infectious arthritis]] | ! rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Infectious arthritis]] | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lyme disease]]<ref name="pmid25999227">{{cite journal| author=Lantos PM| title=Chronic Lyme disease. | journal=Infect Dis Clin North Am | year= 2015 | volume= 29 | issue= 2 | pages= 325-40 | pmid=25999227 | doi=10.1016/j.idc.2015.02.006 | pmc=4477530 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25999227 }}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lyme disease]]<ref name="pmid25999227">{{cite journal| author=Lantos PM| title=Chronic Lyme disease. | journal=Infect Dis Clin North Am | year= 2015 | volume= 29 | issue= 2 | pages= 325-40 | pmid=25999227 | doi=10.1016/j.idc.2015.02.006 | pmc=4477530 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25999227 }}</ref> | ||
Line 79: | Line 79: | ||
! style="background: #F5F5F5; padding: 5px;" |↑[[WBC]], [[Staphylococcus aureus|S. aureus]] in culture | ! style="background: #F5F5F5; padding: 5px;" |↑[[WBC]], [[Staphylococcus aureus|S. aureus]] in culture | ||
! style="background: #F5F5F5; padding: 5px;" |[[Hypergammaglobulinemia|Hyperglobulinemia]], [[Cryoglobulinemia]] | ! style="background: #F5F5F5; padding: 5px;" |[[Hypergammaglobulinemia|Hyperglobulinemia]], [[Cryoglobulinemia]] | ||
! style="background: #F5F5F5; padding: 5px;" |Joint erosion and effusion | ! style="background: #F5F5F5; padding: 5px;" |[[Erosion (dental)|Joint erosion]] and effusion | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 225: | Line 225: | ||
! style="background: #F5F5F5; padding: 5px;" |[[Rheumatoid nodules]] | ! style="background: #F5F5F5; padding: 5px;" |[[Rheumatoid nodules]] | ||
|- | |- | ||
! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[ | ! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Crystal arthritis|Crystal-induced arthritis]]'''<ref name="pmid62879632">{{cite journal |vauthors=Reginato A, Paul H, Schumacher HR |title=Crystal-induced arthritis |journal=Arch Phys Med Rehabil |volume=63 |issue=9 |pages=401–8 |date=September 1982 |pmid=6287963 |doi= |url=}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
! style="background: #F5F5F5; padding: 5px;" |+/- | ! style="background: #F5F5F5; padding: 5px;" |+/- | ||
Line 251: | Line 232: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Joint [[erythema]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Leukocytosis]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Needle shaped [[urate]] crystals, [[WBC]] count > 2000/µL | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Urinary [[uric acid]] (>1100 mg in 24h) | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Punched-out erosions or [[lytic]] areas with overhanging edges | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Complementary for recognizing [[Erosion (dental)|erosions]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Tophus|Tophi]] or [[edema]] in [[MRI]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Large pale pink acellular areas ([[Uric acid|urate crystals]]), surrounded by [[histiocytes]] and [[multinucleated giant cells]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Synovial fluid]] assay | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Conjunctival|Conjunctival nodules]] | ||
|- | |- | ||
! rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Systemic [[Rheumatic disease|rheumatic illnesses]]''' | ! rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Systemic [[Rheumatic disease|rheumatic illnesses]]''' | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic lupus erythematosus]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic lupus erythematosus]]<ref name="pmid16722594">{{cite journal| author=Manson JJ, Rahman A| title=Systemic lupus erythematosus. | journal=Orphanet J Rare Dis | year= 2006 | volume= 1 | issue= | pages= 6 | pmid=16722594 | doi=10.1186/1750-1172-1-6 | pmc=1459118 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16722594 }}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 271: | Line 252: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Malar rash]], [[Photosensitivity]], [[Discoid lupus]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Leukopenia]], [[Lymphopenia]], [[Anemia]], [[Thrombocytopenia]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Cell count from < 25% [[PMNs]] (non-[[inflammatory]] effusions) to > 50% [[PMNs]] ([[inflammatory]] effusions) | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Creatine kinase]], [[Liver function tests|LFT]], [[ANA]], [[Anti-dsDNA antibody|Anti-dsDNA]], [[Anti-SM antibody|Anti-Sm]], [[Lupus anticoagulant]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Periarticular [[osteopenia]] and [[Soft tissue injury|soft-tissue swelling]] without [[Erosion (dental)|erosions]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Interstitial lung disease]], [[Pneumonitis]], [[Pulmonary emboli]], [[Alveolar Cyst Disease|Alveolar hemorrhage]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Pericardial effusion]], [[Pulmonary hypertension]], [[Libman-Sacks endocarditis|Verrucous Libman-Sacks endocarditis]] in [[echocardiography]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Inflammatory]] infiltrates at the dermoepidermal junction and vacuolar change in the basal [[Columnar epithelium|columnar cells]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Anti-dsDNA antibody|Anti-dsDNA]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Rheumatoid arthritis]], [[Serositis]], [[Oral ulcers]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic vasculitis]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic vasculitis]]<ref name="pmid27964796">{{cite journal |vauthors=Watts RA, Scott DG |title=Vasculitis and inflammatory arthritis |journal=Best Pract Res Clin Rheumatol |volume=30 |issue=5 |pages=916–931 |date=October 2016 |pmid=27964796 |doi=10.1016/j.berh.2016.10.008 |url=}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 290: | Line 271: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Petechia]], [[Purpura]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Anemia]], [[Thrombocytosis]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[P-ANCA]], [[C-ANCA]][[ANA|, ANA]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Soft tissue pathology|Soft tissue swelling]] with mild [[Erosion (dental)|erosions]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Focal regions of [[infarction]] or [[hemorrhage]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Multiple [[Aneurysm|microaneurysms]],[[Hemorrhage]] due to focal [[rupture]], [[Occlusion]] in [[angiography]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Acute destruction of the [[Tunica media|media]] by [[neutrophils]], with loss of [[elastic fibers]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Angiography]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Peripheral neuropathy]], [[Livedo reticularis]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic sclerosis]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic sclerosis]]<ref name="AvouacClements2012">{{cite journal|last1=Avouac|first1=J.|last2=Clements|first2=P. J.|last3=Khanna|first3=D.|last4=Furst|first4=D. E.|last5=Allanore|first5=Y.|title=Articular involvement in systemic sclerosis|journal=Rheumatology|volume=51|issue=8|year=2012|pages=1347–1356|issn=1462-0324|doi=10.1093/rheumatology/kes041}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 309: | Line 290: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |3 phases of (1) [[Edema|Edematous]], (2) [[Induration|Indurative]], and (3) [[Atrophic]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Thrombocytopenia]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Cell count < 25% [[PMNs]] (non-[[inflammatory]]) | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Hypergammaglobulinemia]], | ||
! style="background: #F5F5F5; padding: 5px;" | | |||
! style="background: #F5F5F5; padding: 5px;" | | [[Creatine phosphokinase]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Juxta-[[articular]] [[osteoporosis]], Joint space narrowing, Frank [[Erosion (dental)|erosions]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Synovial inflammation]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Synovial]] [[vascularity]] in [[doppler ultrasonography]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Epidermal]] [[skin appendages]] [[atrophy]], Broad and hyalinized [[collagen]] fibers in the [[reticular dermis]] | ||
! style="background: #F5F5F5; padding: 5px;" |[[Histopathology]] | |||
! style="background: #F5F5F5; padding: 5px;" |[[Raynaud phenomenon]], [[Tendon]] [[Friction rub|friction rubs]] | |||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polymyositis]]/[[dermatomyositis]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polymyositis]]/[[dermatomyositis]]<ref name="pmid12895397">{{cite journal |vauthors=Briemberg HR, Amato AA |title=Dermatomyositis and Polymyositis |journal=Curr Treat Options Neurol |volume=5 |issue=5 |pages=349–356 |date=September 2003 |pmid=12895397 |doi= |url=}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 328: | Line 311: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Heliotropism|Heliotrope rash]], [[Dermatomyositis|Gottron papules]], [[Poikiloderma of civatte|Poikiloderma]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Normocytic normochromic anemia]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Predominantly [[mononuclear cells]] and large macrophage-like cells | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Anti–Mi-2 antibodies, Anti–Jo-1 antibodies, [[Creatine kinase]], [[ANA]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Marginal [[Erosion (dental)|erosions]] and periarticular [[calcification]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Vacuolar changes of the [[columnar epithelium]] and [[lymphocytic]] [[Infiltration (medical)|infiltrates]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Muscle biopsy]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Dysphagia]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Still's disease]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Still's disease]]<ref name="pmid25613167">{{cite journal |vauthors=Kadavath S, Efthimiou P |title=Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options |journal=Ann. Med. |volume=47 |issue=1 |pages=6–14 |date=February 2015 |pmid=25613167 |doi=10.3109/07853890.2014.971052 |url=}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 347: | Line 330: | ||
! style="background: #F5F5F5; padding: 5px;" |+/- | ! style="background: #F5F5F5; padding: 5px;" |+/- | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Mild [[papules]] and [[nodules]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Anemia]], [[Thrombocytosis]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |High [[WBC]] count (5000-15,000/µL) with >50% of [[PMN|PMN leukocytes]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[ANA]], [[RF]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Soft tissue swelling, | ||
! style="background: #F5F5F5; padding: 5px;" | | |||
! style="background: #F5F5F5; padding: 5px;" | | [[Osteopenia]], | ||
! style="background: #F5F5F5; padding: 5px;" | | |||
! style="background: #F5F5F5; padding: 5px;" | | Joint-space narrowing | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Synovial inflammation]] | ||
! style="background: #F5F5F5; padding: 5px;" |Inflamed [[synovium]] in [[ultrasonography]] | |||
! style="background: #F5F5F5; padding: 5px;" |[[Inflammatory]] [[Infiltration (medical)|infiltration]] in [[synovium]] | |||
! style="background: #F5F5F5; padding: 5px;" |Clinical findings and [[synovial fluid]] analysis | |||
! style="background: #F5F5F5; padding: 5px;" |[[Ocular|Ocular involvement]] | |||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Behçet's disease|Behçet's syndrome]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Behçet's disease|Behçet's syndrome]] |
Revision as of 14:35, 30 April 2018
Template:DiseaseDisorder infobox
WikiDoc Resources for Polyarthritis |
Articles |
---|
Most recent articles on Polyarthritis Most cited articles on Polyarthritis |
Media |
Powerpoint slides on Polyarthritis |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Polyarthritis at Clinical Trials.gov Trial results on Polyarthritis Clinical Trials on Polyarthritis at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Polyarthritis NICE Guidance on Polyarthritis
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Polyarthritis Discussion groups on Polyarthritis Patient Handouts on Polyarthritis Directions to Hospitals Treating Polyarthritis Risk calculators and risk factors for Polyarthritis
|
Healthcare Provider Resources |
Causes & Risk Factors for Polyarthritis |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Polyarthritis is any type of arthritis which involves five or more joints - an inflammation of two, three or four joints is an oligoarthritis.
Causes
Polyarthritis is most often caused by an auto-immune disorder such as Rheumatoid arthritis, Psoriatic arthritis, and Lupus erythematosus but can also be caused by infections such as Ross River Virus.
Differential Diagnosis of Diseases That Cause Polyarthritis
References
- ↑ Lantos PM (2015). "Chronic Lyme disease". Infect Dis Clin North Am. 29 (2): 325–40. doi:10.1016/j.idc.2015.02.006. PMC 4477530. PMID 25999227.
- ↑ Soor P, Sharma N, Rao C (2017). "Multifocal Septic Arthritis Secondary to Infective Endocarditis: A Rare Case Report". J Orthop Case Rep. 7 (1): 65–68. doi:10.13107/jocr.2250-0685.692. PMC 5458702. PMID 28630844.
- ↑ Kumar RK, Tandon R (2013). "Rheumatic fever & rheumatic heart disease: the last 50 years". Indian J Med Res. 137 (4): 643–58. PMC 3724245. PMID 23703332.
- ↑ Colmegna I, Cuchacovich R, Espinoza LR (2004). "HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations". Clin Microbiol Rev. 17 (2): 348–69. PMC 387405. PMID 15084505.
- ↑ Hill Gaston, J (2003). "Arthritis associated with enteric infection". Best Practice & Research Clinical Rheumatology. 17 (2): 219–239. doi:10.1016/S1521-6942(02)00104-3. ISSN 1521-6942.
- ↑ McVeigh CM, Cairns AP (2006). "Diagnosis and management of ankylosing spondylitis". BMJ. 333 (7568): 581–5. doi:10.1136/bmj.38954.689583.DE. PMC 1570004. PMID 16974012.
- ↑ Sankowski AJ, Lebkowska UM, Cwikła J, Walecka I, Walecki J (2013). "Psoriatic arthritis". Pol J Radiol. 78 (1): 7–17. doi:10.12659/PJR.883763. PMC 3596149. PMID 23493653.
- ↑ Orchard TR (2012). "Management of arthritis in patients with inflammatory bowel disease". Gastroenterol Hepatol (N Y). 8 (5): 327–9. PMC 3424429. PMID 22933865.
- ↑ Heidari B (2011). "Rheumatoid Arthritis: Early diagnosis and treatment outcomes". Caspian J Intern Med. 2 (1): 161–70. PMC 3766928. PMID 24024009.
- ↑ Reginato A, Paul H, Schumacher HR (September 1982). "Crystal-induced arthritis". Arch Phys Med Rehabil. 63 (9): 401–8. PMID 6287963.
- ↑ Manson JJ, Rahman A (2006). "Systemic lupus erythematosus". Orphanet J Rare Dis. 1: 6. doi:10.1186/1750-1172-1-6. PMC 1459118. PMID 16722594.
- ↑ Watts RA, Scott DG (October 2016). "Vasculitis and inflammatory arthritis". Best Pract Res Clin Rheumatol. 30 (5): 916–931. doi:10.1016/j.berh.2016.10.008. PMID 27964796.
- ↑ Avouac, J.; Clements, P. J.; Khanna, D.; Furst, D. E.; Allanore, Y. (2012). "Articular involvement in systemic sclerosis". Rheumatology. 51 (8): 1347–1356. doi:10.1093/rheumatology/kes041. ISSN 1462-0324.
- ↑ Briemberg HR, Amato AA (September 2003). "Dermatomyositis and Polymyositis". Curr Treat Options Neurol. 5 (5): 349–356. PMID 12895397.
- ↑ Kadavath S, Efthimiou P (February 2015). "Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options". Ann. Med. 47 (1): 6–14. doi:10.3109/07853890.2014.971052. PMID 25613167.